335 related articles for article (PubMed ID: 16609045)
1. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
[TBL] [Abstract][Full Text] [Related]
2. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
[TBL] [Abstract][Full Text] [Related]
3. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
Newby JC; Johnston SR; Smith IE; Dowsett M
Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
[TBL] [Abstract][Full Text] [Related]
5. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Di Lorenzo G; Tortora G; D'Armiento FP; De Rosa G; Staibano S; Autorino R; D'Armiento M; De Laurentiis M; De Placido S; Catalano G; Bianco AR; Ciardiello F
Clin Cancer Res; 2002 Nov; 8(11):3438-44. PubMed ID: 12429632
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas.
Araki K; Hashimoto K; Ardyanto TD; Osaki M; Shomori K; Nakamura H; Ito H
Lung Cancer; 2004 Aug; 45(2):161-9. PubMed ID: 15246187
[TBL] [Abstract][Full Text] [Related]
8. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
11. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
13. The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast.
Jeziorski A; Blonski JZ; Niewiadomska H
J Exp Clin Cancer Res; 2000 Mar; 19(1):61-7. PubMed ID: 10840938
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
15. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
17. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
Merrick DT; Haney J; Petrunich S; Sugita M; Miller YE; Keith RL; Kennedy TC; Franklin WA
Lung Cancer; 2005 Apr; 48(1):31-45. PubMed ID: 15777969
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
